Shandong Pharmaceutical Glass Co.Ltd Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Shandong Pharmaceutical Glass Co.Ltd Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Shandong Pharmaceutical Glass Co.Ltd were recently set by distinguished experts, with an average mark of ¥35.60. If it reached this goal, it would represent a potential upside of approximately 26.33% from the previous closing price in May, 2024. The high end is ¥38.01, and the low is ¥30.60. If you're looking for information on Shandong Pharmaceutical Glass Co.Ltd stock, consider checking out the forecasts for comparable firms such as XTRA:GXI.
26.33% Upside
Shandong Pharmaceutical Glass Co.Ltd Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Shandong Pharmaceutical Glass Co.Ltd has seen a decline in its Price, from ¥26.11 to ¥0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ¥40.70 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Shandong Pharmaceutical Glass Co.Ltd will be 100.00%.
Shandong Pharmaceutical Glass Co.Ltd Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Revenue for Shandong Pharmaceutical Glass Co.Ltd has grown by 45.38%, going from ¥3.43B to ¥4.98B. According to the 0 analysts polled, in the next year, Shandong Pharmaceutical Glass Co.Ltd's Revenue will fall by 11.66%, reaching ¥4.40B. By 2030, professionals believe that Shandong Pharmaceutical Glass Co.Ltd's Revenue will have decreased by 12.63%, falling to ¥4.35B.
.jpg)
Shandong Pharmaceutical Glass Co.Ltd Dividend per Share Forecast for 2023 - 2025 - 2030
Shandong Pharmaceutical Glass Co.Ltd's Dividend per Share has grown in the last three years, jumping from ¥0.30 to ¥0.40 – an increase of 33.33%. In the next year, analysts predict that Dividend per Share will reach ¥0.46 – an increase of 15.00%. For the next seven years, the forecast is for Dividend per Share to grow by 29.98%.
Shandong Pharmaceutical Glass Co.Ltd EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Shandong Pharmaceutical Glass Co.Ltd's EBITDA has grown, increasing from ¥877.06M to ¥1.17B – an increase of 33.78%. For next year, the 4 analysts predict EBITDA of ¥1.50B, which would mean an increase of 27.62%. Over the next seven years, the pros' prediction is EBITDAof ¥1.71B, which would mean a seven-year growth forecast of 45.74%.
Shandong Pharmaceutical Glass Co.Ltd EBIT Forecast for 2023 - 2025 - 2030
Shandong Pharmaceutical Glass Co.Ltd's EBIT has increased by 28.68% In the last three years, going from ¥659.43M to ¥848.58M. In the next year, analysts expect EBIT to reach ¥1.13B – an increase of 33.18%. For the next seven years, the forecast is for EBIT to grow by 50.91%.
Shandong Pharmaceutical Glass Co.Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Shandong Pharmaceutical Glass Co.Ltd has seen a decline in its EPS, from ¥0.93 to ¥0.00 – a 100.00% decrease. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ¥1.45 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Shandong Pharmaceutical Glass Co.Ltd will be 100.00%.
Site Navigation
.jpg)